uridine monophosphate has been researched along with Dyskeratosis Congenita, X-Linked in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alter, BP; Giri, N; Khincha, PP; Savage, SA; Wong, JM; Xu, J | 1 |
1 trial(s) available for uridine monophosphate and Dyskeratosis Congenita, X-Linked
| Article | Year |
|---|---|
Investigation of chromosome X inactivation and clinical phenotypes in female carriers of DKC1 mutations.
Topics: Adolescent; Adult; Aged; Case-Control Studies; Cell Cycle Proteins; Cell Line; Dyskeratosis Congenita; Epigenesis, Genetic; Female; Germ-Line Mutation; Heterozygote; Humans; Middle Aged; Mosaicism; Nuclear Proteins; Phenotype; RNA; Telomerase; Uridine Monophosphate; X Chromosome Inactivation; Young Adult | 2016 |